Literature DB >> 15176765

Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments.

David L Penn1, Kim T Mueser, Nick Tarrier, Andrew Gloege, Corrine Cather, Daniel Serrano, Michael W Otto.   

Abstract

This article posits that the positive findings for supportive therapy (ST) in recent trials may indicate an important but undervalued aspect of psychosocial interventions for schizophrenia. In developing this thesis, we consider the possible mechanisms underlying the beneficial effects of ST observed in recent trials of cognitive behavioral therapy for schizophrenia. We place this evidence in the context of a review of psychological models of mental health, the therapeutic alliance, and research on social cognition and social support in schizophrenia. We conclude this article by describing a new theoretically driven intervention for schizophrenia, functional cognitive-behavioral therapy (FCBT), which improves functional outcomes by integrating evidence-based advances in cognitive behavioral therapy with the strengths of ST approaches.

Entities:  

Mesh:

Year:  2004        PMID: 15176765     DOI: 10.1093/oxfordjournals.schbul.a007055

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

1.  Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment.

Authors:  Stefan Klingberg; Andreas Wittorf; Jutta Herrlich; Georg Wiedemann; Christoph Meisner; Gerhard Buchkremer; Nicole Frommann; Wolfgang Wölwer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

2.  Have the potential benefits of CBT for severe mental disorders been undersold?

Authors:  Kim T Mueser; Shirley M Glynn
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Development of novel behavioral interventions in an experimental therapeutics world: Challenges, and directions for the future.

Authors:  Kathryn E Lewandowski; Dost Ongur; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

Review 4.  [Evidence basis of psychotherapy for schizophrenia patients in Germany].

Authors:  B Puschner; R Vauth; F Jacobi; T Becker
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

5.  Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study.

Authors:  Stefan Klingberg; Wolfgang Wölwer; Corinna Engel; Andreas Wittorf; Jutta Herrlich; Christoph Meisner; Gerhard Buchkremer; Georg Wiedemann
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Randomized trial of supported employment integrated with assertive community treatment for rural adults with severe mental illness.

Authors:  Paul B Gold; Neil Meisler; Alberto B Santos; Mark A Carnemolla; Olivia H Williams; Jennie Keleher
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

7.  The pursuit of euthymia.

Authors:  Giovanni A Fava; Jenny Guidi
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

Review 8.  Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families.

Authors:  Josef Bäuml; Teresa Froböse; Sibylle Kraemer; Michael Rentrop; Gabriele Pitschel-Walz
Journal:  Schizophr Bull       Date:  2006-08-18       Impact factor: 9.306

9.  Social disinterest attitudes and group cognitive-behavioral social skills training for functional disability in schizophrenia.

Authors:  Eric Granholm; Dror Ben-Zeev; Peter C Link
Journal:  Schizophr Bull       Date:  2009-07-23       Impact factor: 9.306

10.  Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome.

Authors:  Eric Granholm; Jason Holden; Peter C Link; John R McQuaid; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-10       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.